Condition: Epithelial Ovarian Cancer · Sponsor: Japanese Gynecologic Oncology Group
To compare the Overall survival of adjuvant chemotherapy versus observation in stage I epithelial ovarian cancer after comprehensive staging surgery
This description comes directly from the study's public registry record.
Hiroshi Tanabe, M.D. · 81-4-7133-1111 · htanabe@east.ncc.go.jp
Always discuss trial participation with your own doctor first.
| Aichi Medical University Hospital | Nagakute-shi, Aichi-ken, Japan | Recruiting |
| Tosei General Hospital | Seto-shi, Aichi-ken, Japan | Recruiting |
| Fujita Health University Hospital | Toyoake-shi, Aichi-ken, Japan | Recruiting |
| Hirosaki University School of Medicine & Hospital | Hirosaki-shi, Aomori, Japan | Recruiting |
| The Jikei University School of Medicine Kashiwa Hospital | Kashiwa-shi, Chiba, Japan | Recruiting |
| National Cancer Center Hospital East | Kashiwa-shi, Chiba, Japan | Recruiting |
| Ehime University Hospital | Onsen-gun, Ehime, Japan | Recruiting |
| Kyusyu Medical Center | Fukuoka, Fukuoka, Japan | Recruiting |
| Kyusyu Cancer Center | Fukuoka, Fukuoka, Japan | Recruiting |
| Kyushu University Hospital | Fukuoka, Fukuoka, Japan | Recruiting |
| Kurume University Hospital | Kurume-shi, Fukuoka, Japan | Recruiting |
| Gifu University Hospital | Gifu, Gifu, Japan | Recruiting |
+ 91 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04063527